7 CrossFit Athletes Banned From Competition for Drug Policy Breach

We’re hours away from the announcement of CrossFit Open Workout 20.1, and CrossFit HQ just published a press release that lists seven athletes who have received bans for being in breach of their drug policy. 

Earlier today, we reported on a 4-year ban that 2019 CrossFit Games athlete Katie Trombetta had received for violating CrossFit’s drug policy, and she is among one of the seven athletes that have been provided in CrossFit HQ’s latest press release linked above. In the press release, CrossFit HQ notes that all of the tests were administered between the dates of July 29th and August 19th.

It appears that five of the seven athletes received their drug tests during the 2019 CrossFit Games, while two athletes from Argentenia who finished in the top 20 in the Open for their country received tests in mid-August. 

In addition and as noted in the press release, all of the athletes have concluded their appeals process and only one athlete has received a two-year ban due to a contaminated supplement, while the other six athletes have received four year bans from competition.

Check out the full list of athletes below, along with what they tested positive for which was provided in CrossFit HQ’s press release. 

• Katie Trombetta, 44^th-ranked individual at the 2019 Games – Tested positive for metabolites of GW1516 and ostarine. 
• Franky Wood, 87^th-ranked individual at the 2019 Games – Tested positive for 3-hydroxy-4-methoxytamoxifen, a metabolite of tamoxifen.
• Achilleas Pantazis, 126^th-ranked individual at the 2019 Games – Tested positive for GW1516 sulfoxide and GW1516 sulfone, metabolites of GW1516. 
• Anna Fragkou, 9^th-ranked individual at the 2019 Games – Tested positive for a metabolite of oral turinabol (4-chloro-18-nor-17β-hydroxymethyl,17α-methyl-5α-androst-13-en-3α-ol). 

• Hylie Thompson, 4^th-ranked Masters 55-59 at the 2019 Games – Tested positive for GW1516 sulfoxide and GW1516 sulfone, metabolites of GW1516.
• Mauro Acevedo, 3^rd-ranked individual in Argentina after the 2019 Open – Tested positive for oral turinabol and its metabolite 6β-OH-Dehydrochloromethyltestosterone. 
• Juan Sforzini, 16^th-ranked individual in Argentina after the 2019 Open – Tested positive for stanozolol metabolites (4β-hydroxystanozolol and 16β-hydroxystanozolol).

Feature image from @anna.fragkou Instagram page.